NeuroVive Appoints CEO
This article was originally published in Scrip
NeuroVive Pharmaceutcial AB has named Erik Kinnman CEO, succeeding interim CEO Jan Nilsson, who will resume his position as chief operating officer for the company – effective March 14, 2016. Kinnman has held various roles in clinical development, business strategy, business development and investor relations in biopharmaceutical companies including AstraZeneca and Sobi and also has experience in the financial sector.
Register for our free email digests: